TuHURA Biosciences HURA
NASDAQ HURA
$2.00 -0.22 (-9.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Shares Outstanding (2010 - 2026)

TuHURA Biosciences (HURA) posted quarterly Shares Outstanding (Entity) of $63.6 million for Q1 2026, up 45.55% year-over-year from $43.7 million in Q1 2025, and up 32.66% quarter-over-quarter from $47.9 million in Q4 2025.

TuHURA Biosciences (HURA) Shares Outstanding (2010 - 2026) Analysis & Trends

TuHURA Biosciences' Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $63.6 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Entity) rose 45.55% year-over-year to $63.6 million; the TTM figure through Mar 2026 stood at $63.6 million (up 45.55% YoY), while the FY2025 annual figure was $47.9 million, up 156.81% from the prior year.
  • Shares Outstanding (Entity) for Q1 2026 stood at $63.6 million, up from $47.9 million in the prior quarter.
  • The five-year high for Shares Outstanding (Entity) was $63.6 million in Q1 2026, with the low at $27828.0 in Q2 2022.
  • The 5-year median for Shares Outstanding (Entity) is $1.3 million (2024), against an average of $17.1 million.
  • The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) advanced 8.03% in 2023, then surged 25093.47% in 2024.
  • TuHURA Biosciences' Shares Outstanding (Entity) stood at $47798.0 in 2022, then surged by 159.23% to $123908.0 in 2023, then surged by 14961.73% to $18.7 million in 2024, then surged by 156.81% to $47.9 million in 2025, then surged by 32.66% to $63.6 million in 2026.
  • Business Quant data shows HURA's Shares Outstanding (Entity) at $63.6 million in Q1 2026, $47.9 million in Q4 2025, and $51.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 TuHURA Biosciences 37.61 Mn 37.61 Mn - 18.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 60.01 Mn
Dec 31, 2025 47.93 Mn
Sep 30, 2025 50.67 Mn
Jun 30, 2025 44.56 Mn
Mar 31, 2025 43.40 Mn
Dec 31, 2024 18.66 Mn
Sep 30, 2024 1.59 Mn
Jun 30, 2024 12.18 Mn
Mar 31, 2024 1.27 Mn
Dec 31, 2023 123,908.00
Sep 30, 2023 49,083.00
Jun 30, 2023 46,283.00
Mar 31, 2023 48,026.00
Dec 31, 2022 46,941.00
Sep 30, 2022 41,829.00
Jun 30, 2022 27,828.00
Mar 31, 2022 28,072.00
Dec 31, 2021 27,729.00
Sep 30, 2021 19,588.00
Jun 30, 2021 14,791.00